1. 23andMe Study: Genetic Markers May Predict Weight Loss, Side Effects on GLP-1 Drugs
A new study from 23andMe suggests a person's genetics could be a key factor in determining how well they respond to blockbuster GLP-1 weight-loss drugs like Wegovy and Zepbound. Published in *Nature*, the research identifies specific changes in two genes that appear to help predict not only whether a patient will lose ...